Document is current
Any future updates will be listed below
-
Authors
Bergamasco, Aurore https://orcid.org/0000-0001-8361-9746
Luyet-Déruaz, Anouk https://orcid.org/0000-0001-7396-7392
Gollop, Nicholas D. https://orcid.org/0000-0002-8105-9404
Moride, Yola https://orcid.org/0000-0002-8753-2274
Qiao, Qing https://orcid.org/0000-0002-2549-6415
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim
- License Information
-
More Information
Article History
Accepted: 9 March 2022
First Online: 30 March 2022
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: AB reports grants from Boehringer Ingelheim International GmbH, during the conduct of the study, and is an employee of YolaRX Consultants. ADL, NDG, and QQ are employees of Boehringer Ingelheim International GmbH. YM reports grants from Boehringer Ingelheim International GmbH, during the conduct of the study, and is the president of YolaRX Consultants.
